Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
7.62
+0.15 (2.01%)
Apr 28, 2025, 4:00 PM EDT - Market closed

Journey Medical Statistics

Total Valuation

Journey Medical has a market cap or net worth of $175.13 million. The enterprise value is $180.53 million.

Market Cap 175.13M
Enterprise Value 180.53M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

Journey Medical has 23.10 million shares outstanding. The number of shares has increased by 12.06% in one year.

Current Share Class 17.10M
Shares Outstanding 23.10M
Shares Change (YoY) +12.06%
Shares Change (QoQ) +3.77%
Owned by Insiders (%) 6.65%
Owned by Institutions (%) 16.32%
Float 12.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.76
Forward PS 2.27
PB Ratio 8.37
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.22
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.28.

Current Ratio 1.37
Quick Ratio 0.87
Debt / Equity 1.28
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.07

Financial Efficiency

Return on equity (ROE) is -72.60% and return on invested capital (ROIC) is -20.39%.

Return on Equity (ROE) -72.60%
Return on Assets (ROA) -10.88%
Return on Invested Capital (ROIC) -20.39%
Return on Capital Employed (ROCE) -30.35%
Revenue Per Employee $1.37M
Profits Per Employee -$357,854
Employee Count 41
Asset Turnover 0.71
Inventory Turnover 1.69

Taxes

In the past 12 months, Journey Medical has paid $61,000 in taxes.

Income Tax 61,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +124.12% in the last 52 weeks. The beta is 0.91, so Journey Medical's price volatility has been similar to the market average.

Beta (5Y) 0.91
52-Week Price Change +124.12%
50-Day Moving Average 5.92
200-Day Moving Average 5.31
Relative Strength Index (RSI) 67.95
Average Volume (20 Days) 108,605

Short Selling Information

The latest short interest is 252,109, so 1.09% of the outstanding shares have been sold short.

Short Interest 252,109
Short Previous Month 150,053
Short % of Shares Out 1.09%
Short % of Float 2.07%
Short Ratio (days to cover) 2.57

Income Statement

In the last 12 months, Journey Medical had revenue of $56.13 million and -$14.67 million in losses. Loss per share was -$0.72.

Revenue 56.13M
Gross Profit 35.26M
Operating Income -13.68M
Pretax Income -3.94M
Net Income -14.67M
EBITDA -10.25M
EBIT -13.68M
Loss Per Share -$0.72
Full Income Statement

Balance Sheet

The company has $20.31 million in cash and $25.71 million in debt, giving a net cash position of -$5.40 million or -$0.23 per share.

Cash & Cash Equivalents 20.31M
Total Debt 25.71M
Net Cash -5.40M
Net Cash Per Share -$0.23
Equity (Book Value) 20.07M
Book Value Per Share 0.91
Working Capital 13.00M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.13M
Capital Expenditures n/a
Free Cash Flow -9.13M
FCF Per Share -$0.40
Full Cash Flow Statement

Margins

Gross margin is 62.81%, with operating and profit margins of -24.36% and -26.14%.

Gross Margin 62.81%
Operating Margin -24.36%
Pretax Margin -26.03%
Profit Margin -26.14%
EBITDA Margin -18.27%
EBIT Margin -24.36%
FCF Margin n/a

Dividends & Yields

Journey Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -12.06%
Shareholder Yield -12.06%
Earnings Yield -8.38%
FCF Yield -5.21%

Analyst Forecast

The average price target for Journey Medical is $10.00, which is 31.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 31.23%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Journey Medical has an Altman Z-Score of -0.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.23
Piotroski F-Score 2